Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| 1 |
Merck
MRK
|
+$512M |
| 2 |
Microsoft
MSFT
|
+$371M |
| 3 |
Apple
AAPL
|
+$361M |
| 4 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$350M |
| 5 |
Cisco
CSCO
|
+$317M |
Top Sells
| 1 |
Novartis
NVS
|
+$423M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$390M |
| 3 |
SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$351M |
| 4 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$349M |
| 5 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$343M |
Sector Composition
| 1 | Technology | 23.07% |
| 2 | Financials | 12.4% |
| 3 | Healthcare | 11.8% |
| 4 | Consumer Discretionary | 10.03% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Anika Therapeutics
ANIK
$125M
| $2.68M | ﹤0.01% |
118,157
+4,546
| +4% | +$103K |
|
2527
Arhaus
ARHS
$1.58B
| $2.67M | ﹤0.01% |
225,336
+4,038
| +2% | +$47.9K |
|
2528
iQIYI
IQ
$2.57B
| $2.67M | ﹤0.01% |
547,175
-46,466
| -8% | -$227K |
|
2529
Advantage Solutions
ADV
$606M
| $2.67M | ﹤0.01% |
736,469
+12,880
| +2% | +$46.6K |
|
|
TSVT
2530
DELISTED
2seventy bio
TSVT
| $2.64M | ﹤0.01% |
619,315
+74,413
| +14% | +$318K |
|
2531
Prime Medicine
PRME
$829M
| $2.62M | ﹤0.01% |
296,188
+3,618
| +1% | +$32.1K |
|
2532
MasterCraft Boat Holdings
MCFT
$364M
| $2.61M | ﹤0.01% |
115,101
-12,871
| -10% | -$291K |
|
2533
Distribution Solutions Group
DSGR
$1.42B
| $2.6M | ﹤0.01% |
82,328
+3,406
| +4% | +$107K |
|
2534
LanzaTech
LNZA
$43.7M
| $2.59M | ﹤0.01% |
5,146
+238
| +5% | +$120K |
|
2535
Unilever
UL
$153B
| $2.58M | ﹤0.01% |
53,131
+1,773
| +3% | +$86K |
|
2536
Biomea Fusion
BMEA
$117M
| $2.57M | ﹤0.01% |
176,797
+2,369
| +1% | +$34.4K |
|
2537
Coherus Oncology, Inc. Common Stock
CHRS
$157M
| $2.56M | ﹤0.01% |
767,697
+44,325
| +6% | +$148K |
|
|
CRGX
2538
DELISTED
CARGO Therapeutics
CRGX
| $2.56M | ﹤0.01% |
+110,395
| New | +$2.56M |
|
2539
Kodiak Gas Services
KGS
$2.86B
| $2.55M | ﹤0.01% |
127,098
+3,220
| +3% | +$64.7K |
|
2540
Financial Institutions
FISI
$532M
| $2.55M | ﹤0.01% |
119,602
-1,778
| -1% | -$37.9K |
|
2541
Johnson Outdoors
JOUT
$425M
| $2.55M | ﹤0.01% |
47,655
+38
| +0.1% | +$2.03K |
|
2542
NewtekOne
NEWT
$317M
| $2.54M | ﹤0.01% |
183,702
+1,948
| +1% | +$26.9K |
|
2543
Bank of Marin Bancorp
BMRC
$395M
| $2.53M | ﹤0.01% |
114,872
-3,038
| -3% | -$66.9K |
|
2544
Cullinan Oncology
CGEM
$350M
| $2.51M | ﹤0.01% |
246,705
+16,719
| +7% | +$170K |
|
2545
American Well
AMWL
$105M
| $2.5M | ﹤0.01% |
83,843
-13,683
| -14% | -$408K |
|
2546
Summit Therapeutics
SMMT
$13.4B
| $2.49M | ﹤0.01% |
953,846
+13,050
| +1% | +$34.1K |
|
2547
Forrester Research
FORR
$207M
| $2.48M | ﹤0.01% |
92,558
-213
| -0.2% | -$5.71K |
|
2548
Xponential Fitness
XPOF
$285M
| $2.46M | ﹤0.01% |
191,173
-3,282
| -2% | -$42.3K |
|
2549
Lyell Immunopharma
LYEL
$236M
| $2.46M | ﹤0.01% |
63,343
+807
| +1% | +$31.3K |
|
2550
Microvast
MVST
$1.09B
| $2.44M | ﹤0.01% |
1,741,880
+280,818
| +19% | +$393K |
|